Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
With some radiopharmaceuticals now used in clinical practice, somatostatin analogs [...]
Real-world data analysis of efficacy and survival after Lu-177 PSMA
177Lu-PSMA radioligand therapy provides a significant response rate with a [...]
PSMA Lu-177 x Ac-225
Available since 2015, the treatment of patients with metastatic castration-resistant [...]
Oncidium foundation welcomes it’s Turkish Ambassador
Welcome Mr. Hasan Ulaş Özcan as an Oncidium foundation Ambassador [...]
Oncidium foundation is a corporate member of the SNMMI Value Initiative
The Oncidium foundation is a corporate member of the Society [...]
Nuclear Medicine and Molecular Imaging Week: October 4-10, 2020
October 4-10 2020 is nuclear medicine and molecular imaging week! [...]
First clinical results for PSMA TAT using Ac-225-PSMA-I&T in advanced mCRPC patients
First clinical results for PSMA targeted alpha therapy using 225Ac-PSMA-I&T [...]
IAEA activities on Cu-67, Re-186, Sc-47 Theranostic radionuclides and Radiopharmaceuticals
International Atomic Energy Agency (IAEA) activities on 67Cu, 186Re, 47Sc [...]
The Role of Ga-68-FAPI PET/CT for Malignancies of the Lower GI Tract
The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of [...]
Cancer awareness month – September, don’t forget to remember
The month of September represents the prostate cancer, thyroid cancer, [...]